FrancophonIA/ELRC3.0 huggingface dataset:
English: Fluenz Tetra demonstrated immunologic non-inferiority to the two formulations of Fluenz as the upper bound for each of the four 95% CIs for the post-dose strain-specific GMT HAI antibody ratios was ≤ 1.5.
Croatian: Fluenz Tetra pokazao je imunološku neinferiornost u odnosu na dvije formulacije cjepiva Fluenz jer je gornja granica za svaka od četiri 95% CI-ja za omjer soj-specifičnih antitijela GMT HAI nakon doziranja bila ≤ 1,5.
English: Children less than 24 months of age should not receive this vaccine because of the risk of side effects.
Croatian: Djeca mlađa od 24 mjeseca ne bi trebala primiti ovo cjepivo jer postoji rizik od nuspojava.
English: Ask your doctor, nurse or pharmacist if you want more information about possible side effects from Fluenz Tetra.
Croatian: Pitajte svog liječnika, medicinsku sestru ili ljekarnika za dodatne informacije o mogućim nuspojavama cjepiva Fluenz Tetra.
English: - Children and adolescents younger than 18 years of age receiving salicylate therapy because of the association of Reye's syndrome with salicylates and wild-type influenza infection.
Croatian: - Djeca i adolescenti mlađi od 18 godina koji primaju terapiju salicilatima, zbog povezanosti Reyevog sindroma s primjenom salicilata i infekcijom divljim tipom virusa influence.
English: Depress the plunger With a single motion, depress plunger as rapidly as possible until the dose-divider clip prevents you from going further.
Croatian: Pritisnite klip Jednim pokretom pritisnite klip što je brže moguće, koliko Vam to dopusti razdjeljivač doze.
English: Do not administer Fluenz Tetra to children and adolescents receiving salicylate therapy (see section 4.3).
Croatian: Ne primjenjujte Fluenz Tetra u djece i adolescenata koji primaju terapiju salicilatima (vidjeti dio 4.3).
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.
Croatian: Detaljnije informacije o ovom lijeku dostupne su na internetskoj stranici Europske agencije za lijekove http://www.ema.europa.eu/
English: What Fluenz Tetra is and what it is used for What you need to know before you are given Fluenz Tetra How Fluenz Tetra is given
Croatian: Što je Fluenz Tetra i za što se koristi Što morate znati prije nego počnete primati Fluenz Tetra
English: - Hypersensitivity to the active substances, to any of the excipients listed in section 6.1 (e.g. gelatin), or to gentamicin (a possible trace residue).
Croatian: - Preosjetljivost na djelatne tvari, neku od pomoćnih tvari navedenih u dijelu 6.1 (npr., želatinu), ili na gentamicin (moguća ostatna tvar).
English: Do not inject Fluenz Tetra.
Croatian: Nemojte injicirati Fluenz Tetra.
English: No data exist regarding the possible effects of Fluenz Tetra on male and female fertility.
Croatian: Ne postoje podaci o mogućim učincima cjepiva Fluenz Tetra na mušku i žensku plodnost.
English: The effectiveness of Fluenz and Fluenz Tetra in preventing influenza illness in immunocompromised individuals has not been evaluated.
Croatian: Učinkovitost cjepiva Fluenz i Fluenz Tetra u prevenciji bolesti influence u imunokompromitiranih osoba nije ispitana.
English: Any unused medicinal product or waste material should be disposed of in accordance with local requirements for medical waste.
Croatian: Neiskorišteni lijek ili otpadni materijal potrebno je zbrinuti sukladno nacionalnim propisima za zbrinjavanje medicinskog otpada.
English: Uncommon: Hypersensitivity reactions (including facial oedema, urticaria and very rare anaphylactic reactions)
Croatian: Manje često: reakcije preosjetljivosti (uključujući edem lica, urtikariju i vrlo rijetke anafilaktičke reakcije)
English: In clinical studies, the safety profile of Fluenz Tetra was similar to the safety profile of Fluenz.
Croatian: U kliničkim ispitivanjima, sigurnosni profil cjepiva Fluenz Tetra bio je sličan sigurnosnom profilu cjepiva Fluenz.
English: In 24 HIV-infected children and 25 HIV-negative children 1 through 7 years of age, and in 243 HIV-infected children and adolescents 5 through 17 years of age receiving stable anti-retroviral therapy, the frequency and duration of vaccine virus shedding were comparable to that seen in healthy individuals.
Croatian: U 24 djece zaražene HIV-om i 25 HIV-negativne djece u dobi od 1 do 7 godina, i u 243 djeteta i adolescenta zaražena HIV-om u dobi od 5 do 17 godina koji primaju stabilnu antiretrovirusnu terapiju, učestalost i trajanje izlučivanja virusa cjepiva usporedivi su s onim u zdravih pojedinaca.
English: However, a conclusion on clinical benefit of this vaccine in adults could not be made given that results observed in some studies versus injectable influenza vaccines were suggestive of a lower efficacy of Fluenz.
Croatian: Međutim, ne može se donijeti zaključak o kliničkoj koristi ovog cjepiva kod odraslih s obzirom da su rezultati dobiveni u nekim ispitivanjima pokazali slabiju djelotvornost cjepiva Fluenz u odnosu na cjepivo protiv influence koje se injicira.
English: Fluenz's efficacy data in the paediatric population consist of 9 controlled studies comprising over 20,000 infants and toddlers, children and adolescents, conducted during 7 influenza seasons.
Croatian: Podaci o djelotvornosti cjepiva Fluenz u pedijatrijskoj populaciji prikupljeni su u 9 kontroliranih ispitivanja provedenih na više od 20 000 dojenčadi, male djece, djece i adolescenata tijekom 7 sezona influence.
English: The suspension is colourless to pale yellow, clear to opalescent with a pH of approximately 7.2.
Croatian: Suspenzija je bezbojna do blijedo žuta, bistra do opalescentna, sa pH od približno 7,2.
English: However, based upon the potential for influenza antiviral agents to reduce the effectiveness of Fluenz Tetra, it is recommended not to administer the vaccine until 48 hours after the cessation of influenza antiviral therapy.
Croatian: Međutim, budući da antivirusni lijekovi protiv influence mogu smanjiti učinkovitost cjepiva Fluenz Tetra, ne preporučuje se primijeniti cjepivo prije nego što protekne 48 sati od prestanka antivirusne terapije protiv influence.
English: The patient can breathe normally while the vaccine is being administered - there is no need to actively inhale or sniff.
Croatian: Pacijent može normalno disati tijekom primjene cjepiva - nema potrebe za aktivnim udisanjem ili ušmrkavanjem.
English: What Fluenz Tetra is and what it is used for
Croatian: Što je Fluenz Tetra i za što se koristi
English: What you need to know before you are given Fluenz Tetra
Croatian: Što morate znati prije nego počnete primati Fluenz Tetra
English: fewer cases than injectable fewer cases than injectable
Croatian: manje slučajeva nego s cjepivom koje se injicira manje slučajeva nego s cjepivom koje se injicira
English: No data exist regarding the safety of intranasal administration of Fluenz Tetra in children with unrepaired craniofacial malformations.
Croatian: Ne postoje podaci o sigurnosti intranazalne primjene cjepiva Fluenz Tetra u djece s nekorigiranim kraniofacijalnim malformacijama.
English: Remove dose-divider clip
Croatian: Uklonite razdjeljivač doze
English: Children who have not previously had an influenza vaccine will receive a second, follow-up dose after an interval of at least 4 weeks.
Croatian: Djeca koja nisu prethodno primala cjepivo protiv gripe primit će drugu, dodatnu dozu cjepiva nakon razdoblja od najmanje 4 tjedna.
English: The recommended dose for children and adolescents is 0.2 ml Fluenz Tetra, administered as 0.1 ml in each nostril.
Croatian: Preporučena doza za djecu i adolescente je 0,2 ml cjepiva Fluenz Tetra, primijenjeno kao 0,1 ml u svaku nosnicu.
English: Table 1 Fluenz Efficacy in Placebo Controlled Paediatric Studies
Croatian: Tablica 1: Djelotvornost cjepiva Fluenz u placebom kontroliranim pedijatrijskim ispitivanjima
English: See section 6.6 for administration instructions.
Croatian: Za upute o primjeni, vidjeti dio 6.6.
English: As with most vaccines, appropriate medical treatment and supervision should always be readily available to manage an anaphylactic event or serious hypersensitivity event following the administration of Fluenz Tetra.
Croatian: Kao i kod primjene većine cjepiva, uvijek treba biti dostupno odgovarajuće medicinsko liječenje i nadzor cijepljenika u slučaju anafilaktičke reakcije ili ozbiljne preosjetljivosti nakon primjene cjepiva Fluenz Tetra.
English: The primary circulating strain was antigenically dissimilar from the H3N2 strain represented in the vaccine; efficacy against the mismatched A/H3N2 strain was 85.9% (95% CI: 75.3, 91.9).
Croatian: Primarni cirkulirajući soj bio je po antigenima različit od soja H3N2 koji je bio prisutan u cjepivu; djelotvornost naspram nepodudarnog soja A/H3N2 iznosila je 85,9% (95% CI: 75,3; 91,9).
English: Fluenz Tetra should not be used in infants and toddlers below 24 months of age because of safety concerns regarding increased rates of hospitalisation and wheezing in this population (see section 4.8).
Croatian: Fluenz Tetra se ne smije primjenjivati kod dojenčadi i djece mlađe od 24 mjeseca zbog sigurnosnih razloga vezanih za povećanu stopu hospitalizacija i piskanja pri disanju u ovoj populaciji (vidjeti dio 4.8).
English: In a study (D153-P515) of children 6 to 17 years of age with asthma (trivalent Fluenz: n=1,114, trivalent injectable influenza vaccine: n=1,115), there were no significant differences between treatment groups in the incidence of asthma exacerbations, mean peak expiratory flow rate, asthma symptom scores, or night-time awakening scores.
Croatian: U ispitivanju (D153-P515) djece u dobi od 6 do 17 godina s astmom (trovalentni Fluenz: n = 1,114, trovalentno injekcijsko cjepivo protiv influence: n = 1115), nije bilo značajne razlike između skupina bolesnika u incidenciji egzacerbacije astme, srednjoj vršnoj vrijednosti brzine ekspiratornog protoka, skoru simptoma astme, ili skoru noćnog buđenja.
English: • The patient can breathe normally while the vaccine is being administered - there is no need to actively inhale or sniff.
Croatian: • Pacijent može normalno disati tijekom primjene cjepiva - nema potrebe za aktivnim udisanjem ili ušmrkavanjem.
English: A total of 2,312 children and adolescents were randomised by site at a 3:1:1 ratio to receive either Fluenz Tetra or one of two formulations of comparator vaccine Fluenz, each containing a B strain that corresponded to one of the two B strains in Fluenz Tetra (a B strain of the Yamagata lineage and a B strain of the Victoria lineage).
Croatian: Ukupno 2,312 djece i adolescenata randomiziranih u omjeru 3:1:1 prema dobivanju cjepiva Fluenz Tetra ili jedne od dvije formulacije cjepiva Fluenz, od kojih svaka sadrži tip B soj koji odgovara jednom od dvaju tip B sojeva u cjepivu Fluenz Tetra (tip B soj linije Yamagata i tip B soj linije Victoria).
English: Safety data regarding use of Fluenz Tetra are based on data from Fluenz Tetra clinical studies in 2,231 children and adolescents 2 to 17 years of age, Fluenz clinical studies in over 29,000 children and adolescents 2 to 17 years of age and Fluenz post-authorisation safety studies in over 84,000 children and adolescents 2 to 17 years of age.
Croatian: Podaci o sigurnosti primjene cjepiva Fluenz Tetra temelje se na podacima iz kliničkih ispitivanja cjepiva Fluenz Tetra na 2231 djece i adolescenata u dobi od 2 do 17 godina, kliničkih ispitivanja cjepiva Fluenz na više od 29 000 djece i adolescenata u dobi od 2 do 17 godina te iz ispitivanja sigurnosti nakon stavljanja cjepiva Fluenz u promet na više od 84 000 djece i adolescenata u dobi od 2 do 17 godina.
English: Fluenz Tetra is not contraindicated for use in individuals with asymptomatic HIV infection; or individuals who are receiving topical/inhaled corticosteroids or low-dose systemic corticosteroids or those receiving corticosteroids as replacement therapy, e.g. for adrenal insufficiency.
Croatian: Primjena cjepiva Fluenz Tetra nije kontraindicirana kod osoba s asimptomatskom HIV infekcijom ili onih koji primaju topikalne/inhalacijske kortikosteroide ili niske doze sistemskih kortikosteroida ili u onih koji primaju kortikosteroide kao nadomjesnu terapiju, npr. kod insuficijencije nadbubrežne žlijezde.
English: Fluenz Tetra is not indicated for use in infants and toddlers younger than 24 months (see section 4.2).
Croatian: Fluenz Tetra nije indiciran za primjenu kod dojenčadi i male djece mlađe od 24 mjeseca (vidjeti dio 4.2).
English: D153-P502 Europe 6 to 35 M 1,616
Croatian: D153-P502 Europa od 6 do 35 M 1616
English: - Children and adolescents with clinical immunodeficiency due to conditions or immunosuppressive therapy such as: acute and chronic leukaemias; lymphoma; symptomatic HIV infection; cellular immune deficiencies; and high-dose corticosteroids.
Croatian: - Djeca i adolescenti s kliničkom imunodeficijencijom zbog bolesti ili imunosupresivne terapije kao što je to slučaj kod akutne i kronične leukemije, limfoma; simptomatske HIV infekcije; deficijencije staničnog imuniteta te visokih doza kortikosteroida.
English: This vaccine complies with the WHO recommendations (Northern Hemisphere) and EU decision for the 2019/2020 season.
Croatian: Ovo cjepivo odgovara preporuci SZO (za sjevernu hemisferu) i odluci EU za sezonu 2019/2020.
English: Administration of influenza antiviral agents within two weeks of vaccination may affect the response of the vaccine.
Croatian: Primjena antivirusnih lijekova protiv influence u razdoblju od dva tjedna nakon cijepljenja može utjecati na odgovor na cijepljenje.
English: The incidence of wheezing within 15 days after vaccination was lower in Fluenz recipients relative to inactivated vaccine recipients (19.5% vs. 23.8%, P=0.02).
Croatian: Incidencija piskanja pri disanju u razdoblju od 15 dana nakon cijepljenja bila je niža u primatelja cjepiva Fluenz u odnosu primatelje inaktiviranog cjepiva (19,5% prema 23,8%, P = 0,02).
English: Twenty mild to moderately immunocompromised children and adolescents 5 through 17 years of age (receiving chemotherapy and/or radiation therapy or who had recently received chemotherapy) were randomised 1:1 to trivalent Fluenz or placebo.
Croatian: Dvadesetero blago do umjereno imunokompromitirane djece i adolescenata u dobi od 5 do 17 godina starosti (koji primaju kemoterapiju i/ili radioterapiju ili koji su nedavno primili kemoterapiju) randomizirano je 1:1 prema primanju trovalentnog cjepiva Fluenz ili placeba.
English: He or she will decide if Fluenz Tetra is suitable for you.
Croatian: Oni će odlučiti je li Fluenz Tetra prikladno cjepivo za Vas.
English: However, this alteration might not be of clinical relevance with the two dose immunisation schedule of the rubella vaccine.
Croatian: Međutim, ta promjena možda nije klinički značajna s obzirom na to da se cjepivo protiv rubele daje u dvije doze.
English: - Severe allergic reaction (e.g. anaphylaxis) to eggs or to egg proteins (e.g. ovalbumin).
Croatian: - teška alergijska reakcija (npr. anafilaksija) na jaja ili na proteine jaja (npr. ovalbumin).
English: Fluenz Tetra should not be administered to children and adolescents with severe asthma or active wheezing because these individuals have not been adequately studied in clinical studies.
Croatian: Fluenz Tetra ne treba primjenjivati u djece i adolescenata s teškom astmom ili prisutnim piskanjem pri disanju, jer se u tih osoba nisu provela odgovarajuća klinička ispitivanja.
English: In studies of adults in which a high percentage of individuals had underlying chronic medical conditions, the safety profile of trivalent Fluenz was comparable to the safety profile observed in individuals without these conditions.
Croatian: U ispitivanjima odraslih osoba od kojih visok postotak imao kronična medicinska stanja, sigurnosni profil trovalentnog cjepiva Fluenz usporediv je sa sigurnosnim profilom opaženim u pojedinaca koji nemaju ta stanja.
English: No adverse effects on HIV viral load or CD4 counts were identified following trivalent Fluenz administration.
Croatian: Nisu opaženi štetni učinci na HIV virusni titar ili broj CD4 stanica nakon primjene trovalentnog cjepiva Fluenz.
English: In an active-controlled clinical study (MI-CP111), an increased rate of hospitalisations (for any cause) through 180 days after final vaccination dose was observed in infants and toddlers 6-11 months of age (6.1% Fluenz versus 2.6% injectable influenza vaccine).
Croatian: U aktivno kontroliranom kliničkom ispitivanju (MI-CP111) primijećena je povećana stopa hospitalizacija (iz bilo kojeg razloga) dojenčadi i male djece u dobi od 6 do 11 mjeseci tijekom 180 dana nakon posljednje doze cjepiva Fluenz (6,1% nakon cjepiva Fluenz naspram 2,6% nakon cjepiva protiv influence koje se injicira).
English: Number of study participants for year 1 efficacy analysis.
Croatian: M = mjeseci Broj sudionika istraživanja u prvoj godini analize djelotvornosti c
English: Fluenz has demonstrated superiority in 3 active-controlled studies with injectable influenza vaccine.
Croatian: Fluenz je pokazao superiornost u 3 aktivno kontrolirana ispitivanja u odnosu na cjepivo protiv influence koje se injiciralo.
English: What Fluenz Tetra looks like and contents of the pack
Croatian: Kako Fluenz Tetra izgleda i sadržaj pakiranja
English: Therefore, as some viruses are excreted in human milk, Fluenz Tetra should not be used during breast-feeding.
Croatian: Obzirom da se neki virusi izlučuju u majčino mlijeko, Fluenz Tetra se ne bi trebao primjenjivati tijekom dojenja.
English: Fluenz Tetra Influenza vaccine 2019/2020 season
Croatian: Fluenz Tetra Cjepivo protiv influence Sezona 2019/2020
English: Fluenz Tetra will help to protect against the four virus strains contained in the vaccine, and other strains closely related to them.
Croatian: Fluenz Tetra će vam pomoći da se zaštitite od četiriju sojeva virusa sadržanih u cjepivu te drugih sojeva usko povezanih s njima.
English: You will not be given Fluenz Tetra:
Croatian: Nećete primiti Fluenz Tetra:
English: If influenza antiviral agents and Fluenz Tetra are administered concomitantly, revaccination should be considered based on clinical judgement.
Croatian: Ukoliko se antivirusni lijekovi protiv influence i Fluenz Tetra primijene istodobno, potrebno je razmotriti ponovno cijepljenje prema kliničkoj procjeni.
English: Immunogenicity was evaluated by comparing geometric mean titres (GMTs) of strain-specific serum haemagglutination inhibition (HAI) antibodies post dosing.
Croatian: Imunogenost je ispitana usporedbom geometrijskih srednjih titara (GMT) soj-specifičnih serumskih antitijela inhibicije hemaglutinacije (HAI), poslije doziranja.
English: In a study of children and adolescents 9 to 17 years of age with moderate to severe asthma (trivalent Fluenz: n=24, placebo: n=24), the primary safety criterion, change in percent predicted forced expiratory volume in 1 second (FEV1) measured before and after vaccination, did not differ between treatment arms.
Croatian: U ispitivanju provedenom na djeci i adolescentima u dobi od 9 do 17 godina s umjerenom do teškom astmom (trovalentno cjepivo Fluenz: n=24, placebo: n=24), primarni kriterij sigurnosti, promjena u postocima predviđenoga forsiranoga ekspiratornog volumena u 1 sekundi (FEV1) izmjerenog prije i nakon cijepljenja, nije se razlikovala između terapijskih skupina.
English: Children and adolescents from 24 months: 0.2 ml (administered as 0.1 ml per nostril).
Croatian: Djeca i adolescenti stariji od 24 mjeseca: 0,2 ml (primjenjuje se 0,1 ml po nosnici).
English: No clinically meaningful changes in immune responses to measles, mumps, varicella, orally-administered poliovirus or Fluenz have been observed.
Croatian: Nisu primjećene klinički značajne promjene u imunološkom odgovoru na cjepivo protiv ospica, zaušnjaka, varičele, oralno primijenjenog poliovirusa ili cjepivo Fluenz.
English: Adverse reaction frequencies are reported as: Very common (≥1/10)
Croatian: Učestalost nuspojava prikazana je na sljedeći način: Vrlo često (≥1/10)
English: The suspension should be colourless to pale yellow, clear to opalescent.
Croatian: Suspenzija treba biti bezbojna do blijedo žuta, bistra do opalescentna.
English: Administration of a higher than recommended dose of Fluenz Tetra was reported rarely and the adverse reaction profile was comparable to that observed with the recommended dose of Fluenz Tetra.
Croatian: Rijetko je zabilježena primjena doze cjepiva Fluenz Tetra koja je viša od preporučene, a profil zabilježenih nuspojava bio je sličan onome koji je primijećen s primjenom preporučene doze cjepiva Fluenz Tetra.
English: Fluenz Tetra is a tetravalent vaccine that contains antigens for four influenza virus strains, an A/(H1N1) strain, an A/(H3N2) strain, and two B strains (one from each lineage).
Croatian: Fluenz Tetra je četverovalentno cjepivo koje sadrži antigene za četiri soja virusa influence, tip A/(H1N1) soj, tip A/H3N2 soj, i dva tip B soja (po jedan iz svake linije).
English: Prophylaxis of influenza in children and adolescents from 24 months to less than 18 years of age.
Croatian: Profilaksa influence u djece i adolescenata u dobi od 24 mjeseca do mlađih od 18 godina.
English: Fluenz Tetra has no or negligible influence on the ability to drive and use machines.
Croatian: Fluenz Tetra ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: Do not use salicylates in children and adolescents for 4 weeks after vaccination unless medically indicated as Reye's syndrome has been reported following the use of salicylates during wild-type influenza infection.
Croatian: Nemojte davati salicilate djeci i adolescentima tijekom 4 tjedna nakon cijepljenja osim ako to nije medicinski indicirano, jer je nakon primjene salicilata tijekom infekcije divljim tipom virusa influence zabilježen Reyev sindrom.
English: Fluenz safety
Croatian: Sigurnost cjepiva Fluenz
English: Chronic conditions
Croatian: Kronična stanja
English: Do not use this vaccine after the expiry date which is stated on the applicator label after the letters EXP.
Croatian: Ovo cjepivo se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na naljepnici aplikatora iza oznake „EXP“.
English: 5 single-use nasal applicators (0.2 ml each)
Croatian: 5 aplikatora za nos za jednokratnu uporabu (0,2 ml svaki)
English: Additional experience has occurred with marketed use of Fluenz.
Croatian: Dodatna su iskustva stečena uporabom cjepiva Fluenz nakon njegova stavljanja u promet.
English: The active substances are: Reassortant influenza virus* (live attenuated) of the following four strains**:
Croatian: Djelatne tvari su: Presloženi virus influence* (živi, atenuirani) sljedećih četiriju sojeva**:
English: Fluenz Tetra is a vaccine to prevent influenza (flu).
Croatian: Fluenz Tetra je cjepivo protiv influence (gripe).
English: Reassortant influenza virus* (live attenuated) of the following four strains**:
Croatian: Presloženi virus influence* (živi, atenuirani) sljedećih četiriju sojeva**:
English: Vaccine recipients should be informed that Fluenz Tetra is an attenuated live virus vaccine and has the potential for transmission to immunocompromised contacts.
Croatian: Cijepljene osobe treba upozoriti da je Fluenz Tetra živo atenuirano virusno cjepivo te da postoji mogućnost prijenosa virusa na imunokompromitirane osobe.
English: There is a moderate amount of data from the use of Fluenz Tetra in pregnant women.
Croatian: Postoji određena količina podataka o primjeni cjepiva Fluenz Tetra u trudnica.
English: Fluenz Tetra is supplied as a 0.2 ml suspension in a single-use nasal applicator (Type 1 glass), with nozzle (polypropylene with polyethylene transfer valve), nozzle tip-protector cap (synthetic rubber), plunger rod, plunger-stopper (butyl rubber) and a dose-divider clip.
Croatian: Fluenz Tetra je dostupan u obliku 0,2 ml suspenzije u aplikatoru za nos za jednokratnu uporabu (staklo tip I) s mlaznicom (polipropilen s polietilenskim ventilom za prijenos), zaštitnim zatvaračem vrha mlaznice (sintetička guma), potisnikom klipa, čepom klipa (butilna guma) i razdjeljivačem doze.